Cargando…
Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant Candida parapsilosis
Severely ill COVID-19 patients are at high risk of nosocomial infections. The aim of the study was to describe the characteristics of candidemia during the pre-pandemic period (January 2019–February 2020) compared to the pandemic period (March 2020–September 2021). Antifungal susceptibilities were a...
Autores principales: | Ramos-Martínez, Antonio, Pintos-Pascual, Ilduara, Guinea, Jesús, Gutiérrez-Villanueva, Andrea, Gutiérrez-Abreu, Edith, Díaz-García, Judith, Asensio, Ángel, Iranzo, Reyes, Sánchez-Romero, Isabel, Muñoz-Algarra, María, Moreno-Torres, Víctor, Calderón-Parra, Jorge, Múñez, Elena, Fernández-Cruz, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147669/ https://www.ncbi.nlm.nih.gov/pubmed/35628707 http://dx.doi.org/10.3390/jof8050451 |
Ejemplares similares
-
Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit
por: Pinhati, Henrique Marconi Sampaio, et al.
Publicado: (2016) -
Fluconazole-resistant Candida parapsilosis: A new emerging threat in the fungi arena
por: Escribano, Pilar, et al.
Publicado: (2022) -
Successful Treatment of Candida parapsilosis Fungemia in Two Preterms with Voriconazole
por: Altuncu, Emel, et al.
Publicado: (2015) -
A Brazilian Inter-Hospital Candidemia Outbreak Caused by Fluconazole-Resistant Candida parapsilosis in the COVID-19 Era
por: Thomaz, Danilo Y., et al.
Publicado: (2022) -
Increase in Candida Parapsilosis Candidemia in Cancer Patients
por: Sun, Mingyue, et al.
Publicado: (2019)